Givlaari Injection, Solution
Product Images NDC 71336-1001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Givlaari (NDC 71336-1001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alnylam Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Givosiran 01)

FDA Label Image

Principal Display Panel (189 mg/ml Vial Carton)

Principal Display Panel (189 mg/ml Vial Carton)
This is a product description of a medication called GIVLAARI. It is an injection containing 189 mg/mL of givosiran (as 200 mg of givosiran sodium), along with water for injection USP. The medication is used for subcutaneous injection by healthcare professionals only. The medication is stored at 2°C to 26°C (36°F to 77°F) and should be discarded after use. The medication is manufactured by Ajinomoto Althea, Inc. and is a registered trademark of Alnylam Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.